Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy

類似資料

• Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs
  著者:: Gisondi, Paolo, 等
  出版事項: (2021)
• Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
  著者:: Gisondi, Paolo, 等
  出版事項: (2021)
• The impact of the COVID‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience
  著者:: Gisondi, P., 等
  出版事項: (2020)
• Is SARS‐CoV‐2 screening test indicated for psoriasis patients candidate to biologic therapy?
  著者:: Piaserico, S., 等
  出版事項: (2021)
• Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review
  著者:: Gisondi, Paolo, 等
  出版事項: (2021)